Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    50,606.86
    +1,198.32 (+2.43%)
     
  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

Cardlytics Inc (CDLX) COO Amit Gupta Sells 23,416 Shares

Cardlytics Inc (NASDAQ:CDLX), a company specializing in advertising platforms that leverage purchase intelligence to make marketing more relevant and measurable, has reported an insider sale according to a recent SEC filing. The company's Chief Operating Officer, Amit Gupta, sold 23,416 shares of the company on April 24, 2024. The transaction was executed at an average price of $11.91 per share, resulting in a total sale amount of $278,698.56.

Over the past year, Amit Gupta has been an active seller of Cardlytics Inc stock, disposing of 96,074 shares in total, while not purchasing any shares. This latest transaction continues the trend of insider sales at the company.

The insider transaction history for Cardlytics Inc reveals a pattern of insider activity. In the past year, there have been 17 insider sales and only 2 insider buys. This could suggest that insiders have been more inclined to sell shares than to acquire them.

ADVERTISEMENT

On the valuation front, Cardlytics Inc's shares were trading at $11.91 on the day of the insider's recent sale, giving the company a market capitalization of approximately $554.965 million. According to GuruFocus's valuation analysis, the stock is currently modestly undervalued. The price-to-GF-Value ratio stands at 0.76, with a GF Value of $15.73, indicating that the stock might be trading below its intrinsic value based on historical trading multiples, an adjustment factor for past returns and growth, and future business performance estimates from analysts.

Cardlytics Inc (CDLX) COO Amit Gupta Sells 23,416 Shares
Cardlytics Inc (CDLX) COO Amit Gupta Sells 23,416 Shares

The GF Value is a proprietary intrinsic value estimate from GuruFocus, which takes into account historical price multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company's historical returns and growth, and future business performance forecasts provided by Morningstar analysts.

Cardlytics Inc (CDLX) COO Amit Gupta Sells 23,416 Shares
Cardlytics Inc (CDLX) COO Amit Gupta Sells 23,416 Shares

Investors and stakeholders in Cardlytics Inc may want to monitor insider transactions as they can provide valuable insights into the company's prospects and the perspectives of those who manage it.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.